IL18 and neoplasm: A study showed that the inhibition of IL-18 through TLR2 alleviated mouse HCC progression, whereas deletion of the IL-18 receptor enhanced tumor growth once the IL-18 had tumor-suppressive effects by promoting tumor-infiltration T cells [57].